STOCK TITAN

Stoneridge Financials

SRI
FY2025 annual
Revenue $861.3M -5.2% YoY
Net Income -$102.8M -522.3% YoY
EPS (Diluted) -$3.70 -516.7% YoY
Free Cash Flow $12.2M -48.1% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Stoneridge (SRI) reported $861.3M in revenue for fiscal year 2025, down 5.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SRI FY2025

Stable gross margins but shrinking revenue left overhead under-absorbed, while working-capital release kept cash flow positive.

FY2025 produced $12.2M of free cash flow for a second straight year even as net income fell to -$102.8M. That mismatch reflects a working-capital unwind: as sales softened, receivables and inventory came down, letting the business harvest cash from the balance sheet, so cash conversion looked better than underlying demand and profitability.

Gross margin held near 19.9%, but operating margin fell to -4.5%, which points to cost absorption problems rather than a sudden collapse in product economics. Lower volume had to support a still-heavy overhead structure, and a $47.4M tax expense pushed the net result much deeper than the operating line alone would imply.

The balance-sheet posture also changed character: long-term debt moved from $0 to $180.9M, ending the earlier debt-free posture. Assets slipped to $551.1M while liabilities stayed near $371.3M, so the year's damage was borne mainly by equity rather than by a paydown of obligations or a reduction in leverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 34 / 100
Financial Health Score 34/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Stoneridge's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
25

Stoneridge has an operating margin of -4.5%, meaning the company loses $4 on every $100 of revenue. This results in a profitability score of 25/100. This is down from 0.0% the prior year.

Growth
15

Stoneridge's revenue declined 5.2% year-over-year, from $908.3M to $861.3M. This contraction results in a growth score of 15/100.

Leverage
46

Stoneridge has a moderate D/E ratio of 1.01. This balance of debt and equity financing earns a leverage score of 46/100.

Liquidity
65

With a current ratio of 2.30, Stoneridge holds $2.30 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.

Cash Flow
31

Stoneridge has a free cash flow margin of 1.4%, earning a moderate score of 31/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
21

Stoneridge posts a -57.2% return on equity (ROE), meaning it loses $57 for every $100 of shareholders' equity. This results in a returns score of 21/100. This is down from -6.7% the prior year.

Altman Z-Score Grey Zone
2.30

Stoneridge scores 2.30, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

Stoneridge passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

Stoneridge reported a net loss of $102.8M while generating $34.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$861.3M
YoY-5.2%
5Y CAGR+5.9%
10Y CAGR+2.9%

Stoneridge generated $861.3M in revenue in fiscal year 2025. This represents a decrease of 5.2% from the prior year.

EBITDA
-$6.1M
YoY-118.1%

Stoneridge's EBITDA was -$6.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 118.1% from the prior year.

Net Income
-$102.8M
YoY-522.3%

Stoneridge reported -$102.8M in net income in fiscal year 2025. This represents a decrease of 522.3% from the prior year.

EPS (Diluted)
-$3.70
YoY-516.7%

Stoneridge earned -$3.70 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 516.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$12.2M
YoY-48.1%
5Y CAGR+65.5%
10Y CAGR-7.3%

Stoneridge generated $12.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 48.1% from the prior year.

Cash & Debt
$53.1M
YoY-26.1%
5Y CAGR-6.4%
10Y CAGR-0.2%

Stoneridge held $53.1M in cash against $180.9M in long-term debt as of fiscal year 2025.

Shares Outstanding
28M
YoY+1.2%
5Y CAGR+0.7%
10Y CAGR0.0%

Stoneridge had 28M shares outstanding in fiscal year 2025. This represents an increase of 1.2% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
19.9%
YoY-1.0pp
5Y CAGR-3.9pp
10Y CAGR-7.6pp

Stoneridge's gross margin was 19.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.0 percentage points from the prior year.

Operating Margin
-4.5%
YoY-4.4pp
5Y CAGR-3.3pp
10Y CAGR-8.8pp

Stoneridge's operating margin was -4.5% in fiscal year 2025, reflecting core business profitability. This is down 4.4 percentage points from the prior year.

Net Margin
-11.9%
YoY-10.1pp
5Y CAGR-10.7pp
10Y CAGR-15.5pp

Stoneridge's net profit margin was -11.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 10.1 percentage points from the prior year.

Return on Equity
-57.2%
YoY-50.5pp
5Y CAGR-54.5pp
10Y CAGR-81.7pp

Stoneridge's ROE was -57.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 50.5 percentage points from the prior year.

Capital Allocation

R&D Spending
$62.5M
YoY-13.4%
5Y CAGR+4.8%
10Y CAGR+4.9%

Stoneridge invested $62.5M in research and development in fiscal year 2025. This represents a decrease of 13.4% from the prior year.

Capital Expenditures
$21.9M
YoY-10.1%
5Y CAGR-4.6%
10Y CAGR-2.7%

Stoneridge invested $21.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 10.1% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

SRI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SRI annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$896.9M$861.3M-5.2%$908.3M-6.9%$975.8M+8.4%$899.9M+16.8%$770.5M+18.9%$648.0M-22.3%$834.3M-3.7%$866.2M+5.1%$824.4M+18.5%$696.0M+7.9%$644.8M-2.4%$660.6M+0.2%$659.5M+7.7%$612.5M-20.0%$765.4M
Cost of Revenue$725.6M$690.1M-4.0%$719.0M-7.2%$774.5M+6.8%$725.0M+20.1%$603.6M+22.2%$493.8M-20.4%$620.6M+1.8%$609.6M+5.8%$576.3M+15.1%$500.5M+7.0%$467.8M-0.4%$469.7M+3.6%$453.5M+6.2%$427.2M-30.9%$618.6M
Gross Profit$171.3M$171.2M-9.6%$189.3M-6.0%$201.3M+15.1%$174.9M+4.8%$166.9M+8.2%$154.2M-27.9%$213.7M-16.7%$256.6M+3.4%$248.1M+27.0%$195.4M+10.4%$177.0M-7.3%$190.9M-7.3%$206.0M+11.2%$185.3M+26.2%$146.8M
R&D Expenses$57.4M$62.5M-13.4%$72.2M+1.5%$71.1M+8.9%$65.3M-1.3%$66.2M+34.0%$49.4M-5.4%$52.2M+2.2%$51.1M+4.5%$48.9M+21.5%$40.2M+3.7%$38.8M-6.8%$41.6M+3.1%$40.4M+3.7%$38.9M+10.4%$35.3M
SG&A Expenses$132.6M$125.6M+6.9%$117.5M+0.1%$117.4M+10.0%$106.7M-8.0%$116.0M+3.1%$112.5M-9.2%$123.9M-10.6%$138.6M-2.4%$141.9M+27.7%$111.1M+0.7%$110.4M-10.7%$123.6M+0.4%$123.2M-2.6%$126.4M-1.5%$128.3M
Operating Income-$40.3M-$38.6M-10032.8%-$381K-103.0%$12.8M+337.3%$2.9M-81.0%$15.4M+301.1%-$7.7M-110.8%$71.3M+6.4%$67.0M+16.8%$57.4M+30.1%$44.1M+58.5%$27.8M+207.7%-$25.8M-160.9%$42.4M+113.0%$19.9M+47.2%$13.5M
Interest ExpenseN/AN/AN/A-$13.0M-83.2%-$7.1M-36.8%-$5.2M+15.3%-$6.1M-41.6%-$4.3M+8.4%-$4.7M+18.4%-$5.8M+7.9%-$6.3MN/AN/AN/A$20.0M+16.2%$17.2M
Income Tax$48.2M$47.4M+1518.8%$2.9M-10.2%$3.3M-2.9%$3.4M-62.8%$9.0M+425.5%-$2.8M-134.2%$8.1M-27.7%$11.2M+48.8%$7.5M+120.7%-$36.4M-6552.5%-$547K+70.5%-$1.9M-166.4%$2.8M+8575.8%-$33K-100.1%$26.1M
Net Income-$119.5M-$102.8M-522.3%-$16.5M-218.8%-$5.2M+63.1%-$14.1M-512.7%$3.4M+142.8%-$8.0M-113.2%$60.3M+12.0%$53.8M+19.2%$45.2M-41.7%$77.5M+240.1%$22.8M+148.3%-$47.1M-411.3%$15.1M+182.2%$5.4M-89.1%$49.4M
EPS (Diluted)-$3.70-516.7%-$0.60-215.8%-$0.19+63.5%-$0.52-533.3%$0.12+141.4%-$0.29-113.6%$2.13+15.1%$1.85+17.8%$1.57-42.7%$2.74+238.3%$0.81+146.3%-$1.75-412.5%$0.56+180.0%$0.20-90.0%$2.00

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SRI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SRI annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$551.1M-11.3%$621.6M-8.6%$679.9M+4.3%$652.1M-2.0%$665.4M+7.1%$621.4M+3.2%$602.2M+7.6%$559.5M+0.1%$559.0M+41.7%$394.5M+8.3%$364.3M-8.7%$398.8M-32.2%$588.3M-0.7%$592.7M-14.8%$695.5M
Current Assets$361.8M-6.6%$387.5M-9.8%$429.4M+4.8%$409.6M-0.3%$410.8M+22.8%$334.7M+1.0%$331.3M+3.5%$320.2M+5.5%$303.4M+25.9%$240.9M+3.9%$231.9M-5.5%$245.5M-33.6%$369.6M+18.8%$311.1M-20.1%$389.5M
Cash & Equivalents$53.1M-26.1%$71.8M+75.9%$40.8M-25.5%$54.8M-35.9%$85.5M+15.7%$73.9M+6.5%$69.4M-14.4%$81.1M+22.9%$66.0M+31.0%$50.4M-7.3%$54.4M+26.4%$43.0M-31.5%$62.8M+41.0%$44.6M-43.4%$78.7M
Inventory$106.4M-29.7%$151.3M-19.4%$187.8M+23.1%$152.6M+10.5%$138.1M+52.5%$90.5M-3.1%$93.4M+17.9%$79.3M+7.9%$73.5M+22.2%$60.1M-1.5%$61.0M-14.4%$71.3M-10.4%$79.5M-17.2%$96.0M-20.3%$120.5M
Accounts Receivable$89.0M-35.4%$137.8M-17.3%$166.5M+5.3%$158.2M+5.2%$150.4M+10.0%$136.7M-1.3%$138.6M-0.4%$139.1M-2.4%$142.4M+25.8%$113.2M+19.3%$94.9M-9.7%$105.1M+2.6%$102.4M-27.6%$141.5M-12.8%$162.4M
Goodwill$37.6M+13.6%$33.1M-6.3%$35.3M+3.1%$34.2M-5.9%$36.4M-6.9%$39.1M+9.0%$35.9M-2.3%$36.7M-4.4%$38.4M+4026.6%$931KN/A$1.1M-98.0%$54.3M-12.6%$62.2M-13.4%$71.9M
Total Liabilities$371.3M-1.3%$376.3M-4.1%$392.2M+5.7%$371.2M+0.5%$369.4M+13.8%$324.8M+4.0%$312.3M+13.1%$276.3M-12.3%$315.0M+45.7%$216.2M-20.3%$271.1M-11.8%$307.5M-30.0%$439.3M-0.8%$442.9M-21.5%$564.5M
Current Liabilities$157.5M+5.0%$150.0M-15.9%$178.2M+0.3%$177.7M+2.7%$173.1M+18.5%$146.0M+5.4%$138.6M-5.9%$147.3M+8.2%$136.1M+20.8%$112.7M+4.3%$108.0M-10.2%$120.3M-21.7%$153.7M+0.2%$153.5M-40.5%$257.9M
Long-Term Debt$180.9M$0$0$0$0-100.0%$143.7M+31546.0%$454K-53.8%$983K-74.5%$3.9M-52.2%$8.1M+80.8%$4.5M-58.1%$10.7M-94.2%$185.0M+2.1%$181.3M-1.3%$183.7M
Total Equity$179.8M-26.7%$245.3M-14.8%$287.7M+2.4%$280.9M-5.1%$295.9M-0.2%$296.6M+2.3%$289.9M+2.3%$283.3M+16.1%$244.1M+36.9%$178.3M+91.5%$93.1M+2.0%$91.3M-38.8%$149.0M-0.5%$149.8M+14.3%$131.0M
Retained Earnings$77.2M-57.1%$180.0M-8.4%$196.5M-2.6%$201.7M-6.5%$215.7M+1.6%$212.3M+2.8%$206.5M+41.2%$146.3M+58.5%$92.3M+103.4%$45.4M+241.3%-$32.1M+41.5%-$54.9M-606.2%-$7.8M+66.1%-$22.9M+19.0%-$28.3M

SRI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SRI annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$15.8M$34.0M-28.7%$47.7M+865.4%$4.9M-27.3%$6.8M+118.8%-$36.2M-226.6%$28.6M+16.9%$24.5M-69.7%$80.8M+2.4%$78.9M+20.9%$65.3M+19.1%$54.8M+176.6%$19.8M-54.6%$43.7M-42.2%$75.5M+8102.5%$921K
Capital Expenditures$17.9M$21.9M-10.1%$24.3M-36.9%$38.5M+41.4%$27.2M+18.7%$22.9M-17.0%$27.7M-22.8%$35.8M+23.4%$29.0M-9.8%$32.2M+31.4%$24.5M-14.8%$28.7M+16.1%$24.8M-2.3%$25.3M-3.8%$26.4M+0.2%$26.3M
Free Cash Flow-$2.1M$12.2M-48.1%$23.4M+169.9%-$33.6M-64.3%-$20.4M+65.5%-$59.2M-6134.4%$981K+108.7%-$11.3M-121.9%$51.7M+10.7%$46.7M+14.6%$40.8M+56.5%$26.1M+627.8%-$4.9M-126.9%$18.3M-62.7%$49.2M+293.9%-$25.4M
Investing Cash FlowN/A-$21.8M+10.8%-$24.5M+33.8%-$37.0M-29.4%-$28.6M-201.9%$28.0M+182.8%-$33.9M-437.9%-$6.3M+77.5%-$27.9M+74.3%-$108.6M-356.0%-$23.8M+21.6%-$30.4M-166.4%$45.7M+281.2%-$25.2M+44.7%-$45.6M-53.1%-$29.8M
Financing Cash FlowN/A-$25.3M-327.5%$11.1M-36.4%$17.5M+339.6%-$7.3M-131.9%$22.9M+251.2%$6.5M+123.0%-$28.3M+16.6%-$33.9M-183.0%$40.8M+194.0%-$43.4M-293.6%-$11.0M+86.6%-$82.1M-16213.7%-$503K+99.2%-$65.5M-274.5%$37.5M
Dividends PaidN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$212KN/AN/A
Share BuybacksN/AN/AN/AN/A$0$0-100.0%$5.0M-90.0%$50.0MN/AN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SRI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SRI annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin19.9%-1.0pp20.8%+0.2pp20.6%+1.2pp19.4%-2.2pp21.7%-2.1pp23.8%-1.8pp25.6%-4.0pp29.6%-0.5pp30.1%+2.0pp28.1%+0.6pp27.5%-1.4pp28.9%-2.3pp31.2%+1.0pp30.3%+11.1pp19.2%
Operating Margin-4.5%-4.4pp0.0%-1.4pp1.3%+1.0pp0.3%-1.7pp2.0%+3.2pp-1.2%-9.7pp8.5%+0.8pp7.7%+0.8pp7.0%+0.6pp6.3%+2.0pp4.3%+8.2pp-3.9%-10.3pp6.4%+3.2pp3.3%+1.5pp1.8%
Net Margin-11.9%-10.1pp-1.8%-1.3pp-0.5%+1.0pp-1.6%-2.0pp0.4%+1.7pp-1.2%-8.5pp7.2%+1.0pp6.2%+0.7pp5.5%-5.6pp11.1%+7.6pp3.5%+10.7pp-7.1%-9.4pp2.3%+1.4pp0.9%-5.6pp6.5%
Return on Equity-57.2%-50.5pp-6.7%-4.9pp-1.8%+3.2pp-5.0%-6.2pp1.1%+3.8pp-2.7%-23.5pp20.8%+1.8pp19.0%+0.5pp18.5%-24.9pp43.4%+19.0pp24.5%+76.1pp-51.6%-61.8pp10.2%+6.6pp3.6%-34.1pp37.7%
Return on Assets-18.7%-16.0pp-2.7%-1.9pp-0.8%+1.4pp-2.2%-2.7pp0.5%+1.8pp-1.3%-11.3pp10.0%+0.4pp9.6%+1.5pp8.1%-11.6pp19.6%+13.4pp6.3%+18.1pp-11.8%-14.4pp2.6%+1.7pp0.9%-6.2pp7.1%
Current Ratio2.30-0.3x2.58+0.2x2.41+0.1x2.30-0.1x2.37+0.1x2.29-0.1x2.39+0.2x2.17-0.1x2.23+0.1x2.140.0x2.15+0.1x2.04-0.4x2.40+0.4x2.03+0.5x1.51
Debt-to-Equity1.01+1.0x0.000.0x0.000.0x0.000.0x0.00-0.5x0.48+0.5x0.000.0x0.000.0x0.020.0x0.050.0x0.05-0.1x0.12-1.1x1.240.0x1.21-0.2x1.40
FCF Margin1.4%-1.2pp2.6%+6.0pp-3.4%-1.2pp-2.3%+5.4pp-7.7%-7.8pp0.1%+1.5pp-1.4%-7.3pp6.0%+0.3pp5.7%-0.2pp5.9%+1.8pp4.0%+4.8pp-0.8%-3.5pp2.8%-5.3pp8.0%+11.3pp-3.3%

Similar Companies

Frequently Asked Questions

What is Stoneridge's annual revenue?

Stoneridge (SRI) reported $861.3M in total revenue for fiscal year 2025. This represents a -5.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Stoneridge's revenue growing?

Stoneridge (SRI) revenue declined by 5.2% year-over-year, from $908.3M to $861.3M in fiscal year 2025.

Is Stoneridge profitable?

No, Stoneridge (SRI) reported a net income of -$102.8M in fiscal year 2025, with a net profit margin of -11.9%.

Stoneridge (SRI) reported diluted earnings per share of -$3.70 for fiscal year 2025. This represents a -516.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Stoneridge (SRI) had EBITDA of -$6.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Stoneridge (SRI) had $53.1M in cash and equivalents against $180.9M in long-term debt.

Stoneridge (SRI) had a gross margin of 19.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Stoneridge (SRI) had an operating margin of -4.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Stoneridge (SRI) had a net profit margin of -11.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Stoneridge (SRI) has a return on equity of -57.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Stoneridge (SRI) generated $12.2M in free cash flow during fiscal year 2025. This represents a -48.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Stoneridge (SRI) generated $34.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Stoneridge (SRI) had $551.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Stoneridge (SRI) invested $21.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Stoneridge (SRI) invested $62.5M in research and development during fiscal year 2025.

Stoneridge (SRI) had 28M shares outstanding as of fiscal year 2025.

Stoneridge (SRI) had a current ratio of 2.30 as of fiscal year 2025, which is generally considered healthy.

Stoneridge (SRI) had a debt-to-equity ratio of 1.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Stoneridge (SRI) had a return on assets of -18.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Stoneridge (SRI) has an Altman Z-Score of 2.30, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Stoneridge (SRI) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Stoneridge (SRI) reported a net loss of $102.8M while generating $34.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Stoneridge (SRI) scores 34 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top